Assessment of marketed and in-development products for Alzheimer’s disease: what are the strategic value drivers? by [email protected] | Oct 29, 2023
Pipeline assessment of beta-secretase inhibitors for Alzheimer’s disease: hopes or gloom for a trillion dollar market by [email protected] | Oct 29, 2023
